RecruitingNot ApplicableNCT06204549

Impact of Assessment and Management of Comorbidities in Internal Medicine on Cardiovascular Risk

Impact du Bilan et de la Prise en Charge Des comorbidités en médecine Interne Sur le Risque Cardiovasculaire

Sponsor

University Hospital, Montpellier

Enrollment

70 participants

Start Date

May 21, 2024

Study Type

INTERVENTIONAL

Conditions

Major Adverse Cardiac Events Adverse Cardiac Event

Summary

The aim of assessing and managing cardiovascular risk is to avoid, limit or delay cardiovascular morbidity and mortality. Planned internal medicine hospitalization is developed around the management of cardiovascular risk in patients at high cardiovascular risk, whether in primary prevention or secondary prevention. During planned hospitalization, patients benefit from comprehensive, personalized and adapted care for their comorbidities and their CVRF (cardiovascular risk factors). This study will make it possible to evaluate this overall course of multidisciplinary management of comorbidities of patients at high cardiovascular risk.

Eligibility

Min Age: 18 Years

Inclusion Criteria5

High-Risk Cardiovascular patients either receiving:
Primary prevention because they have never had a cardiovascular event but have several cardiovascular risk factors such as high blood pressure particularly resistant, metabolic syndrome, diabetes , dyslipidemia, metabolic steatosis
Or secondary prevention because they have already had a major cardiovascular event such as ischemic heart disease, heart failure
Aged 18 and over
Patient benefiting from comorbidities assessment during their planned hospitalization in the internal medicine department.

Exclusion Criteria5

Patient refusal
Subject not registered in social security system
Pregnant or breastfeeding woman
Patient unable to give their informed consent, protected adult, vulnerable people
Subject deprived of liberty by judicial or administrative decision

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERScreening and management of cormobidities

During the routine care assessment and as part of the research, patients will : * Fill in cardiovascular risk assessment score: Life's simple 7 * Provide an additional blood sample (1 dry tube of 7 mL and 1 heparin tube of 7 mL) during their biological testing. These samples will be used for lipoprotein (a) testing and biological collection. After hospital discharge, patients will be contacted by telephone at 3 and 12 months for re-evaluation and will fill in the Life's simple 7 score. Prior to this contact, patients will have biological tests as prescribed just before hospital discharge (including blood ionogram, creatinine, liver assessment, lipid assessment (LDL, HDL, triglycerides), fasting blood sugar test, A1C test, urinary albumin/creatinine ratio, protein/ urinary creatinine ratio). They will weigh themselves and take blood pressure self-measurements over 3 days.